Halimatou Diawara
Biographic Data
| ID | 9798034 |
|---|---|
| NAME | Halimatou Diawara |
| GIVEN NAMES | Halimatou |
| FAMILY NAME | Diawara |
| SIGNATURE | DIAWARA H |
| AFFILIATIONS | Université des Sciences, des Techniques et des Technologies de Bamako |
| ORCID | 0000-0001-5361-1532 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Acceptability of the R21/Matrix-M malaria vaccine alongside existing malaria interventions in the trial context
BACKGROUND: The R21/Matrix-M malaria vaccine has been shown to provide high protective efficacy against malaria in a phase III trial, and has been recommended for use by WHO. The vaccine will soon be deployed at scale in sub-Saharan Africa. This study aimed to understand the caregiver and community acceptability of the R21/Matrix-M vaccine alongside existing malaria prevention interventions, according to the communities of participants in the sea…
Estimating the opportunity cost of seasonal malaria chemoprevention implementation in Burkina Faso, Mali and Senegal
Background Seasonal malaria chemoprevention (SMC) is a widely implemented malaria prevention strategy for children under five in the Sahel and sub-Sahel regions of Africa. This study aimed to estimate the full opportunity costs associated with SMC implementation in Mali, Burkina Faso and Senegal, addressing a gap in existing research that often focused solely on health system costs. Using a repeated descriptive cross-sectional design, data were c…
Delivery strategies for malaria vaccination in areas with seasonal malaria transmission
Background Seasonal vaccination with the RTS,S/AS01 E malaria vaccine given alongside seasonal malaria chemoprevention (SMC) substantially reduces malaria in young children. The WHO has recommended the use of RTS,S/AS01 E , including seasonal vaccination, in areas with seasonal malaria transmission. This study aimed to identify potential strategies to deliver RTS,S/AS01 E , and assess the considerations and recommendations for delivery of seasona…
Cost of introducing and delivering malaria vaccine (RTS,S/AS01 E ) in areas of seasonal malaria transmission, Mali and Burkina Faso
BACKGROUND: malaria transmission and suggests countries consider seasonal vaccination in areas with highly seasonal malaria. Seasonal vaccination is uncommon and may require adaptations with potential cost consequences. This study prospectively estimates cost of seasonal malaria vaccine delivery in Mali and Burkina Faso. METHODS: Three scenarios for seasonal vaccine delivery are costed (1) mass campaign only, (2) routine Expanded Programme on Imm…
No prominent works on this page.
Delivery strategies for malaria vaccination in areas with seasonal malaria transmission
Background Seasonal vaccination with the RTS,S/AS01 E malaria vaccine given alongside seasonal malaria chemoprevention (SMC) substantially reduces malaria in young children. The WHO has recommended the use of RTS,S/AS01 E , including seasonal vaccination, in areas with seasonal malaria transmission. This study aimed to identify potential strategies to deliver RTS,S/AS01 E , and assess the considerations and recommendations for delivery of seasona…
Cost of introducing and delivering malaria vaccine (RTS,S/AS01 E ) in areas of seasonal malaria transmission, Mali and Burkina Faso
BACKGROUND: malaria transmission and suggests countries consider seasonal vaccination in areas with highly seasonal malaria. Seasonal vaccination is uncommon and may require adaptations with potential cost consequences. This study prospectively estimates cost of seasonal malaria vaccine delivery in Mali and Burkina Faso. METHODS: Three scenarios for seasonal vaccine delivery are costed (1) mass campaign only, (2) routine Expanded Programme on Imm…
Acceptability of the R21/Matrix-M malaria vaccine alongside existing malaria interventions in the trial context
BACKGROUND: The R21/Matrix-M malaria vaccine has been shown to provide high protective efficacy against malaria in a phase III trial, and has been recommended for use by WHO. The vaccine will soon be deployed at scale in sub-Saharan Africa. This study aimed to understand the caregiver and community acceptability of the R21/Matrix-M vaccine alongside existing malaria prevention interventions, according to the communities of participants in the sea…
Estimating the opportunity cost of seasonal malaria chemoprevention implementation in Burkina Faso, Mali and Senegal
Background Seasonal malaria chemoprevention (SMC) is a widely implemented malaria prevention strategy for children under five in the Sahel and sub-Sahel regions of Africa. This study aimed to estimate the full opportunity costs associated with SMC implementation in Mali, Burkina Faso and Senegal, addressing a gap in existing research that often focused solely on health system costs. Using a repeated descriptive cross-sectional design, data were c…
Malaria (4 works) · Malaria Research and Control (4 works) · Environmental health (3 works) · Global Maternal and Child Health (3 works) · Immunology (3 works) · Malaria vaccine (3 works) · Medicine (3 works) · Plasmodium falciparum (3 works) · Vaccination (3 works) · Nursing (2 works)